Pharma: Clinic Roundup
H. Lundbeck A/S, of Copenhagen, Denmark, reported post hoc analyses at the European College of Neuropsychopharmacology meeting in Vienna, Austria, showing that asenapine achieved significant control of mixed episodes in bipolar I disorder compared to placebo. Asenapine is a tetracyclic antipsychotic therapy.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.